Literature DB >> 11158760

Emergence of multiple human cytomegalovirus ganciclovir-resistant mutants with deletions and substitutions within the UL97 gene in a patient with severe combined immunodeficiency.

D G Wolf1, I Yaniv, S Ashkenazi, A Honigman.   

Abstract

Infection with multiple ganciclovir-resistant human cytomegalovirus mutants, containing different substitutions and deletions in the UL97 gene, was found in a patient with severe combined immunodeficiency (SCID) within 3 weeks of ganciclovir therapy. A novel 11-codon deletion at positions 590 to 600 was identified. These unique findings may be related to the nature of the immunodeficiency in the SCID patient.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158760      PMCID: PMC90332          DOI: 10.1128/AAC.45.2.593-595.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  A nine-codon deletion mutation in the cytomegalovirus UL97 phosphotransferase gene confers resistance to ganciclovir.

Authors:  S Chou; C L Meichsner
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes.

Authors:  S W Chou; K M Dennison
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.

Authors:  H R Rosen; K G Benner; K D Flora; J M Rabkin; S L Orloff; A Olyaei; S Chou
Journal:  Transplantation       Date:  1997-02-15       Impact factor: 4.939

4.  Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase.

Authors:  M S Chee; G L Lawrence; B G Barrell
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

5.  Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates.

Authors:  S Chou; S Guentzel; K R Michels; R C Miner; W L Drew
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

6.  Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

Authors:  S Chou; A Erice; M C Jordan; G M Vercellotti; K R Michels; C L Talarico; S C Stanat; K K Biron
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

7.  The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines.

Authors:  Z He; Y S He; Y Kim; L Chu; C Ohmstede; K K Biron; D M Coen
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma.

Authors:  D G Wolf; I L Smith; D J Lee; W R Freeman; M Flores-Aguilar; S A Spector
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

9.  A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate.

Authors:  F Baldanti; E Silini; A Sarasini; C L Talarico; S C Stanat; K K Biron; M Furione; F Bono; G Palù; G Gerna
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells.

Authors:  V Sullivan; C L Talarico; S C Stanat; M Davis; D M Coen; K K Biron
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

View more
  5 in total

1.  Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.

Authors:  N S Lurain; A Weinberg; C S Crumpacker; S Chou
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 2.  CNS manifestations of cytomegalovirus infections: diagnosis and treatment.

Authors:  Matthias Maschke; Oliver Kastrup; Hans-Christoph Diener
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.

Authors:  Firas El Chaer; Dimpy P Shah; Roy F Chemaly
Journal:  Blood       Date:  2016-10-19       Impact factor: 22.113

Review 4.  Antiviral drug resistance of human cytomegalovirus.

Authors:  Nell S Lurain; Sunwen Chou
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 5.  Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir.

Authors:  Mark N Prichard
Journal:  Rev Med Virol       Date:  2009-07       Impact factor: 6.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.